Postconditioning the human heart in percutaneous coronary intervention

Clinical Cardiology

Volumn 33, Issue 7, 2010, Pages 439-444

  Xue, Feng ^a   Yang, Xiangjun ^a   Zhang, Bing ^a   Zhao, Caiming ^a   Song, Jianping ^a   Jiang, Tingbo ^a   Jiang, Wenping ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; BIOLOGICAL MARKER; CREATINE KINASE MB;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLUDGE CONDITIONING; ADULT; BLOOD; CHINA; ENZYMOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHINA; CREATINE KINASE, MB FORM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; STENTS; STROKE VOLUME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77954910444     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20796     Document Type: Article

References (25)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
2. Piper HM, Meuter K, Schäfer C. Cellularmechanisms of ischemia-reperfusion injury. Ann Thorac Surg. 2003;75:S644-S648.
3. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
4. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-H588.
5. Yang XM, Proctor JB, Cui L, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004; 44: 1103-1110. (Pubitemid 39165147)
6. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74-85. (Pubitemid 38326813)
7. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230-232.
8. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5:587-592. (Pubitemid 15141963)
9. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med. 1985;312:932-936.
10. Syed MA, Borzak S, Asfour A, et al. Single lead ST-segment recovery: a single, reliable measure of successful fibrinolysis after acute myocardial infarction. Am Heart J. 2004;147:275-280.
11. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105: 539-542.
12. Okamoto F, Allen BS, Buckberg GD, et al. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg. 1986;92(3 part 2):613-620.
13. Sato H, Jordan JE, Zhao ZQ, et al. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg. 1997;64:1099-1107. (Pubitemid 27497391)
14. Pisarenko OI, Shulzhenko VS, Studneva IM, et al. Effects of gradual reperfusion on postischemic metabolism and functional recovery of isolated guinea pig heart. Biochem Med Metab Biol. 1993;50:127-134.
15. Penna C, Mancardi D, Raimondo S, et al. The paradigm of postconditioning to protect the heart. J Cell Mol Med. 2008; 12: 435-458.
16. Hausenlloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med. 2005;15:69-75. (Pubitemid 40693390)
17. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation. 2005;112:2143-2148.
18. Crisostmo PR, Wairiuko GM, Wang M, et al. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg. 2006;202:797-812.
19. Santoro GM, Valenti R, Buonamici P, et al. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol. 1998; 82:932-937. (Pubitemid 28480777)
20. Brodie BR, Stuckey TD, Hansen C, et al. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2005;95:343-348. (Pubitemid 40164537)
21. Libby P. Changing concepts of atherogenesis. J Intern Med. 2000; 247: 349-358.
22. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-497. (Pubitemid 38210154)
23. Kennedy TP, Vinten-Johansen J. A review of the clinical use of anti-inflammatory therapies for reperfusion injury in myocardial infarction and stroke: where do we go from here? Curr Opin Investig Drugs. 2006;7:229-242.
24. Ridker PM, Cannon CP, Morrow D, et al; PROVE IT-TIMI 22 Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20-28.
25. Nijmeijer R, Lagrand WK, Visser CA. CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? Int Immunopharmacol. 2001;1:403-414. (Pubitemid 32197539)